ライブラリ登録: Guest
Critical Reviews™ in Eukaryotic Gene Expression

年間 6 号発行

ISSN 印刷: 1045-4403

ISSN オンライン: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Chemokines and Chemokine Receptors as Promoters of Prostate Cancer Growth and Progression

巻 23, 発行 1, 2013, pp. 77-91
DOI: 10.1615/CritRevEukaryotGeneExpr.2013006905
Get accessGet access

要約

Prostate cancer (CaP) is estimated to be first in incidence among cancers, with more than 240,000 new cases in 2012 in the United States. Chemokines and their receptors provide survival, proliferation, and invasion characteristics to CaP cells in both primary sites of cancer and metastatic locations. The emerging data demonstrate that many chemokines and their receptors are involved in the multistep process of CaP, leading to metastasis, and, further, that these factors act cooperatively to enhance other mechanisms of tumor cell survival, growth, and metastasis. Changes of chemokine receptor cohorts may be necessary to activate tumor-promoting signals. Chemokine receptors can activate downstream effectors, such as mitogen-activated protein kinases, by complex mechanisms of ligand-dependent activation of cryptic growth factors; guanosine triphosphate−binding, protein-coupled activation of survival kinases; or transactivation of other receptors such as ErbB family members. We describe vanguard research in which more than the classic view of chemokine receptor biology was clarified. Control of chemokines and inhibition of their receptor activation may add critical tools to reduce tumor growth, especially in chemo-hormonal refractory CaP that is both currently incurable and the most aggressive form of the disease, accounting for most of the more than 28,000 annual deaths.

によって引用された
  1. Chen Guo, Liang Yu-xiang, Zhu Jian-guo, Fu Xin, Chen Yan-fei, Mo Ru-jun, Zhou Liang, Fu Hao, Bi Xue-cheng, He Hui-chan, Yang Sheng-bang, Wu Yong-ding, Jiang Fu-neng, Zhong Wei-de, CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer, BioMed Research International, 2014, 2014. Crossref

  2. Ganguly Sourik S., Li Xiaohong, Miranti Cindy K., The Host Microenvironment Influences Prostate Cancer Invasion, Systemic Spread, Bone Colonization, and Osteoblastic Metastasis, Frontiers in Oncology, 4, 2014. Crossref

  3. Hillerdal Victoria, Essand Magnus, Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer, BioDrugs, 29, 2, 2015. Crossref

  4. Hu Yong-hua, Zhang Jian, CsCCL17, a CC chemokine of Cynoglossus semilaevis, induces leukocyte trafficking and promotes immune defense against viral infection, Fish & Shellfish Immunology, 45, 2, 2015. Crossref

  5. Thapa Dinesh, Ghosh Rita, Chronic inflammatory mediators enhance prostate cancer development and progression, Biochemical Pharmacology, 94, 2, 2015. Crossref

  6. Taverna Gianluigi, Pedretti Elisa, Di Caro Giuseppe, Borroni Elena Monica, Marchesi Federica, Grizzi Fabio, Inflammation and prostate cancer: friends or foe?, Inflammation Research, 64, 5, 2015. Crossref

  7. Wang Lei-Ping, Cao Jun, Zhang Jian, Wang Bi-Yun, Hu Xi-Chun, Shao Zhi-Min, Wang Zhong-Hua, Ou Zhou-Luo, The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells, Medical Oncology, 32, 11, 2015. Crossref

  8. Mo Miao, Zhou Mi, Wang Lu, Qi Lin, Zhou Kehua, Liu Long-Fei, Chen Zhi, Zu Xiong-Bing, Mohanraj Rajesh, CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells, PLOS ONE, 10, 3, 2015. Crossref

  9. Karan Dev, Dubey Seema, From Inflammation to Prostate Cancer: The Role of Inflammasomes, Advances in Urology, 2016, 2016. Crossref

  10. R.S. Reshma, K.H. Sreelatha, Somasundaram Veena, S. Satheesh Kumar, Nadhan Revathy, Nair Rakesh Sathish, Srinivas Priya, Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells, Pharmacological Research, 105, 2016. Crossref

  11. Sciarra Alessandro, Gentilucci Alessandro, Salciccia Stefano, Pierella Federico, Del Bianco Flavio, Gentile Vincenzo, Silvestri Ida, Cattarino Susanna, Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review, Journal of Inflammation, 13, 1, 2016. Crossref

  12. Laurent Victor, Guérard Adrien, Mazerolles Catherine, Le Gonidec Sophie, Toulet Aurélie, Nieto Laurence, Zaidi Falek, Majed Bilal, Garandeau David, Socrier Youri, Golzio Muriel, Cadoudal Thomas, Chaoui Karima, Dray Cedric, Monsarrat Bernard, Schiltz Odile, Wang Yuan Yuan, Couderc Bettina, Valet Philippe, Malavaud Bernard, Muller Catherine, Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity, Nature Communications, 7, 1, 2016. Crossref

  13. Strömvall Kerstin, Thysell Elin, Halin Bergström Sofia, Bergh Anders, Najbauer Joseph, Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis, PLOS ONE, 12, 5, 2017. Crossref

  14. Wang Liang, Zhang Changhua, Xu Jianbo, Wu Hui, Peng Jianjun, Cai Shirong, He Yulong, CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer, Molecular Medicine Reports, 14, 5, 2016. Crossref

  15. Dushyanthen Sathana, Cossigny Davina A.F., Quan Gerald M.Y., The Osteoblastic and Osteoclastic Interactions in Spinal Metastases Secondary to Prostate Cancer, Cancer Growth and Metastasis, 6, 2013. Crossref

  16. Jin Ya-bin, Zhang Guo-yi, Lin Kai-Rong, Chen Xiang-ping, Cui Jin-Huan, Wang Yue-jian, Luo Wei, Sung Shian-Ying, Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT), PLOS ONE, 12, 2, 2017. Crossref

  17. Zhao Yu, The mysterious relation between inflammation and prostate cancer, Infection International, 6, 1, 2017. Crossref

  18. Yang Chenggang, Zheng Wanlei, Du Wenfeng, CXCR3A contributes to the invasion and metastasis of gastric cancer cells, Oncology Reports, 36, 3, 2016. Crossref

  19. Tsai Chin-Hsien, Tzeng Sheue-Fen, Hsieh Shih-Chuan, Yang Yu-Chih, Hsiao Yi-Wen, Tsai Mong-Hsun, Hsiao Pei-Wen, A standardized herbal extract mitigates tumor inflammation and augments chemotherapy effect of docetaxel in prostate cancer, Scientific Reports, 7, 1, 2017. Crossref

  20. Hoy James J., Kallifatidis Georgios, Smith Diandra K., Lokeshwar Bal L., Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival, Scientific Reports, 7, 1, 2017. Crossref

  21. Yildirim Gazi, Attar Rukset, Gulec-Yilmaz Seda, Duman Selvi, Isbir Turgay, Association of CCR2 (+190 G/A) Gene Variants and Ovarian Cancer Severity, Genetic Testing and Molecular Biomarkers, 21, 8, 2017. Crossref

  22. Kumar Sanjay, Singh Rajesh, Malik Shalie, Manne Upender, Mishra Manoj, Prostate cancer health disparities: An immuno-biological perspective, Cancer Letters, 414, 2018. Crossref

  23. SUN JING, FENG CHEN, LIAO WEIWEI, ZHANG HAO, TANG SUOQIN, Expression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy, Oncology Letters, 7, 6, 2014. Crossref

  24. Caggia Silvia, Chunduri HimaBindu, Millena Ana C., Perkins Jonathan N., Venugopal Smrruthi V., Vo BaoHan T., Li Chunliang, Tu Yaping, Khan Shafiq A., Novel role of Giα2 in cell migration: Downstream of PI3‐kinase–AKT and Rac1 in prostate cancer cells, Journal of Cellular Physiology, 234, 1, 2019. Crossref

  25. Ferrer Valéria Pereira, Moura Neto Vivaldo, Mentlein Rolf, Glioma infiltration and extracellular matrix: key players and modulators, Glia, 66, 8, 2018. Crossref

  26. Sun Baiming, Lei Yang, Cao Zhenjie, Zhou Yongcan, Sun Yun, Wu Ying, Wang Shifeng, Guo Weiliang, Liu Chunsheng, TroCCL4, a CC chemokine of Trachinotus ovatus, is involved in the antimicrobial immune response, Fish & Shellfish Immunology, 86, 2019. Crossref

  27. Mancini Andrea, Colapietro Alessandro, Pompili Simona, Del Fattore Andrea, Delle Monache Simona, Biordi Leda Assunta, Angelucci Adriano, Mattei Vincenzo, Liang Chris, Gravina Giovanni Luca, Festuccia Claudio, Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling, Tumor Biology, 40, 4, 2018. Crossref

  28. Rani Aradhana, Dasgupta Prokar, Murphy John J., Prostate Cancer, The American Journal of Pathology, 189, 11, 2019. Crossref

  29. Gong Daoyuan, Wang Yunuo, Wang Yong, Chen Xin, Chen ShenYuan, Wang Ruixue, Liu Lian, Duan Chaohui, Luo Shuhong, Extensive serum cytokine analysis in patients with prostate cancer, Cytokine, 125, 2020. Crossref

  30. Mir Hina, Singh Rajesh, Kloecker Goetz H., Lillard James W., Singh Shailesh, CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases, Oncotarget, 6, 12, 2015. Crossref

  31. Vaidya Foram U., Chhipa Abu Sufiyan, Sagar Nibha, Pathak Chandramani, Oxidative Stress and Inflammation Can Fuel Cancer, in Role of Oxidative Stress in Pathophysiology of Diseases, 2020. Crossref

  32. Nagaya Naoya, Lee Geun Taek, Horie Shigeo, Kim Isaac Yi, CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer, Frontiers in Molecular Biosciences, 7, 2020. Crossref

  33. Salem Anwar, Alotaibi Mashael, Mroueh Rima, Basheer Haneen A., Afarinkia Kamyar, CCR7 as a therapeutic target in Cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1875, 1, 2021. Crossref

  34. He Dan, Zhang Suolin, UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway, Molecular Medicine Reports, 2017. Crossref

  35. Nakamura Noriko, Vijay Vikrant, Sloper Daniel T., Gene expression profiling in dorsolateral prostates of prepubertal and adult Sprague-Dawley rats dosed with estradiol benzoate, estradiol, and testosterone, The Journal of Toxicological Sciences, 45, 8, 2020. Crossref

  36. Liu Peng , Liang Yun , Jiang Libo , Wang Houlei , Wang Shengxing , Dong Jian , CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway, International Journal of Oncology, 2018. Crossref

  37. El-Far Mohamed, Superiority of CCL11x IL-6 over PSA in Prostate Cancer Prediction and Detection in Egyptian Patients: First Preliminary Comparative Assessment, Journal of Cancer Prevention & Current Research, 2, 4, 2015. Crossref

  38. Yang Song, Wang Han, Qin Chundi, Sun Hongmei, Han Yupeng, Up-regulation of CXCL8 expression is associated with a poor prognosis and enhances tumor cell malignant behaviors in liver cancer, Bioscience Reports, 40, 8, 2020. Crossref

  39. Guérard Adrien, Laurent Victor, Fromont Gaëlle, Estève David, Gilhodes Julia, Bonnelye Edith, Le Gonidec Sophie, Valet Philippe, Malavaud Bernard, Reina Nicolas, Attané Camille, Muller Catherine, The Chemokine Receptor CCR3 Is Potentially Involved in the Homing of Prostate Cancer Cells to Bone: Implication of Bone-Marrow Adipocytes, International Journal of Molecular Sciences, 22, 4, 2021. Crossref

  40. Zhu Xuewei, Liu Li, Wang Yang, Cong Jianan, Lin Zhang, Wang Yongsen, Liu Qi, Wang Leiming, Yang Ben, Li Tao, lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma, Frontiers in Oncology, 11, 2021. Crossref

  41. Huang Renlun, Guo Lang, Gao Menghan, Li Jing, Xiang Songtao, Research Trends and Regulation of CCL5 in Prostate Cancer, OncoTargets and Therapy, Volume 14, 2021. Crossref

  42. Li Pupu, Chen Xinfeng, Qin Guohui, Yue Dongli, Zhang Zhen, Ping Yu, Wang Dan, Zhao Xuan, Song Mengjia, Zhao Qitai, Li Jieyao, Liu Shasha, Wang Dong, Zhang Chaoqi, Lian Jingyao, Cao Ling, Li Feng, Huang Lan, Wang Liping, Yang Li, Huang Jianmin, Li Hong, Zhang Bin, Zhang Yi, Maelstrom Directs Myeloid-Derived Suppressor Cells to Promote Esophageal Squamous Cell Carcinoma Progression via Activation of the Akt1/RelA/IL8 Signaling Pathway, Cancer Immunology Research, 6, 10, 2018. Crossref

  43. Hu Yangyang, Lu Lin, Xia Yang, Chen Xin, Chang Alfred E., Hollingsworth Robert E., Hurt Elaine, Owen John, Moyer Jeffrey S., Prince Mark E.P., Dai Fu, Bao Yangyi, Wang Yi, Whitfield Joel, Xia Jian-Chuan, Huang Shiang, Wicha Max S., Li Qiao, Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting, Cancer Research, 76, 16, 2016. Crossref

  44. Zhu Lizhen, Wang Chengju, Jiang Hongyun, Zhang Lan, Mao Liangang, Zhang Yanning, Qi Suzhen, Liu Xingang, Quizalofop-P-ethyl induced developmental toxicity and cardiotoxicity in early life stage of zebrafish (Danio rerio), Ecotoxicology and Environmental Safety, 238, 2022. Crossref

  45. Kallifatidis Georgios, Munoz Daniel, Singh Rajendra Kumar, Salazar Nicole, Hoy James J., Lokeshwar Bal L., β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation, Molecular Cancer Research, 14, 5, 2016. Crossref

  46. Joo Mina, Heo Jong, Kim Solbi, Kim Nayoung, Jeon Heung, An Yueun, Song Gyu-Yong, Kim Jin-Man, Lee Hyo, Decursin inhibits tumor progression in head and neck squamous cell carcinoma by downregulating CXCR7 expression in vitro, Oncology Reports, 47, 2, 2021. Crossref

  47. Chen Ke, Wu Kongming, Jiao Xuanmao, Wang Liping, Ju Xiaoming, Wang Min, Di Sante Gabriele, Xu Shaohua, Wang Qiong, Li Kevin, Sun Xin, Xu Congwen, Li Zhiping, Casimiro Mathew C., Ertel Adam, Addya Sankar, McCue Peter A., Lisanti Michael P., Wang Chenguang, Davis Richard J., Mardon Graeme, Pestell Richard G., The Endogenous Cell-Fate Factor Dachshund Restrains Prostate Epithelial Cell Migration via Repression of Cytokine Secretion via a CXCL Signaling Module, Cancer Research, 75, 10, 2015. Crossref

  48. Mughees Mohd, Kaushal Jyoti Bala, Sharma Gunjan, Wajid Saima, Batra Surinder Kumar, Siddiqui Jawed Akhtar, Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis, Seminars in Cancer Biology, 2022. Crossref

  49. Samadi Abbas K., Bilsland Alan, Georgakilas Alexandros G., Amedei Amedeo, Amin Amr, Bishayee Anupam, Azmi Asfar S., Lokeshwar Bal L., Grue Brendan, Panis Carolina, Boosani Chandra S., Poudyal Deepak, Stafforini Diana M., Bhakta Dipita, Niccolai Elena, Guha Gunjan, Vasantha Rupasinghe H.P., Fujii Hiromasa, Honoki Kanya, Mehta Kapil, Aquilano Katia, Lowe Leroy, Hofseth Lorne J., Ricciardiello Luigi, Ciriolo Maria Rosa, Singh Neetu, Whelan Richard L., Chaturvedi Rupesh, Ashraf S. Salman, Shantha Kumara H.M.C., Nowsheen Somaira, Mohammed Sulma I., Keith W. Nicol, Helferich William G., Yang Xujuan, A multi-targeted approach to suppress tumor-promoting inflammation, Seminars in Cancer Biology, 35, 2015. Crossref

  50. Karpova Yaroslava, Johnson Sarah J., Bordet Guillaume, Guo Danping, Ghatak Atreyi, Markov Dmitriy A., Tulin Alexei V., Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genes, Biomedicine & Pharmacotherapy, 153, 2022. Crossref

  51. Chen Lei, Zheng Yi, Jiang Changqin, Yang Cheng, Zhang Li, Liang Chaozhao, The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies, Frontiers in Immunology, 13, 2022. Crossref

近刊の記事

PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan PURPL promotes M2 macrophage polarization in lung cancer via regulating RBM4/xCT signaling Jipeng Guo, Chongwen Gong, Hao Wang SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain